These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 37489218)

  • 1. Maple Syrup Urine Disease: An Uncommon Cause of Neonatal Febrile Seizures.
    K K H; Ajmera P; Agarwal A; Dahiya A; Parripati VK
    Cureus; 2023 Jun; 15(6):e40826. PubMed ID: 37489218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EEG Pattern in Neonatal Maple Syrup Urine Disease: Description and Clinical Significance.
    Poothrikovil RP; Al Thihli K; Al Futaisi A
    Neurodiagn J; 2021 Sep; 61(3):123-131. PubMed ID: 34449278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imaging Findings in Maple Syrup Urine Disease: A Case Report.
    Kathait AS; Puac P; Castillo M
    J Pediatr Neurosci; 2018; 13(1):103-105. PubMed ID: 29899783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Maple syrup urine disease: magnetic resonance imaging findings in three patients.
    Allahwala A; Ahmed S; Afroze B
    J Pak Med Assoc; 2021 Apr; 71(4):1309-1313. PubMed ID: 34125801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brain magnetic resonance imaging findings and radiologic review of maple syrup urine disease: Report of three cases.
    Li Y; Liu X; Duan CF; Song XF; Zhuang XH
    World J Clin Cases; 2021 Mar; 9(8):1844-1852. PubMed ID: 33748233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imaging in classic form of maple syrup urine disease: a rare metabolic central nervous system.
    Jain A; Jagdeesh K; Mane R; Singla S
    J Clin Neonatol; 2013 Apr; 2(2):98-100. PubMed ID: 24049754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathophysiology of maple syrup urine disease: Focus on the neurotoxic role of the accumulated branched-chain amino acids and branched-chain α-keto acids.
    Amaral AU; Wajner M
    Neurochem Int; 2022 Jul; 157():105360. PubMed ID: 35577033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma amino acid and urine organic acid profiles of Filipino patients with maple syrup urine disease (MSUD) and correlation with their neurologic features.
    Chiong MA; Tan MA; Cordero CP; Fodra EG; Manliguis JS; Lopez CP; Dalmacio LM
    Mol Genet Metab Rep; 2016 Dec; 9():46-53. PubMed ID: 27761412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantification of Branched-Chain Amino Acids in Plasma by High-Performance Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS).
    Piri-Moghadam H; Miller A; Pronger D; Vicente F; Charrow J; Haymond S; Lin DC
    Methods Mol Biol; 2022; 2546():65-81. PubMed ID: 36127579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Second-tier test for quantification of alloisoleucine and branched-chain amino acids in dried blood spots to improve newborn screening for maple syrup urine disease (MSUD).
    Oglesbee D; Sanders KA; Lacey JM; Magera MJ; Casetta B; Strauss KA; Tortorelli S; Rinaldo P; Matern D
    Clin Chem; 2008 Mar; 54(3):542-9. PubMed ID: 18178665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clues and challenges in the diagnosis of intermittent maple syrup urine disease.
    Pode-Shakked N; Korman SH; Pode-Shakked B; Landau Y; Kneller K; Abraham S; Shaag A; Ulanovsky I; Daas S; Saraf-Levy T; Reznik-Wolf H; Vivante A; Pras E; Almashanu S; Anikster Y
    Eur J Med Genet; 2020 Jun; 63(6):103901. PubMed ID: 32151765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maple syrup urine disease: An uncommon cause for neonatal metabolic distress.
    Christopher R; Babu SV; Nirmala L; Rangaswamy GR; Narayan CP; Shetty KT
    Indian J Clin Biochem; 1999 Jul; 14(2):198-206. PubMed ID: 23105219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maple syrup urine disease: mechanisms and management.
    Blackburn PR; Gass JM; Vairo FPE; Farnham KM; Atwal HK; Macklin S; Klee EW; Atwal PS
    Appl Clin Genet; 2017; 10():57-66. PubMed ID: 28919799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of DNA damage by L-carnitine induced by metabolites accumulated in maple syrup urine disease in human peripheral leukocytes in vitro.
    Mescka CP; Wayhs CA; Guerreiro G; Manfredini V; Dutra-Filho CS; Vargas CR
    Gene; 2014 Sep; 548(2):294-8. PubMed ID: 25046137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Maple syrup urine disease in Thai infants.
    Pangkanon S; Charoensiriwatana W; Sangtawesin V
    J Med Assoc Thai; 2008 Oct; 91 Suppl 3():S41-4. PubMed ID: 19255991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adipose transplant for inborn errors of branched chain amino acid metabolism in mice.
    Zimmerman HA; Olson KC; Chen G; Lynch CJ
    Mol Genet Metab; 2013 Aug; 109(4):345-53. PubMed ID: 23800641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxidative stress in plasma from maple syrup urine disease patients during treatment.
    Barschak AG; Sitta A; Deon M; Barden AT; Dutra-Filho CS; Wajner M; Vargas CR
    Metab Brain Dis; 2008 Mar; 23(1):71-80. PubMed ID: 18026828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maple syrup urine disease: clinical, EEG, and plasma amino acid correlations with a theoretical mechanism of acute neurotoxicity.
    Korein J; Sansaricq C; Kalmijn M; Honig J; Lange B
    Int J Neurosci; 1994 Nov; 79(1-2):21-45. PubMed ID: 7744549
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.